4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-027338
CEO and CFO bought 1,000 shares at $9.23 ($9,230)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-09-29 | Purchase | +1,000 | $9.23 | $9,230 | 2,713,886 | D |
| Open-market purchases · 1,000 sh · avg $9.23 · $9,230 | |||||||
Loading xslF345X03/ownership.xml…